Intermittent dosing of nitric oxide gas

Details for Australian Patent Application No. 2005244078 (hide)

Owner Pulmonox Technologies Corporation Sensormedics Corporation Viasys Healthcare

Inventors McMullin, Beven; Miller, Chris; Stenzler, Alex

Agent Spruson & Ferguson

Pub. Number AU-A-2005244078

PCT Pub. Number WO2005/110441

Priority 60/570,429 11.05.04 US

Filing date 11 May 2005

Wipo publication date 24 November 2005

International Classifications

A61M 11/00 (2006.01) Sprayers

A61M 15/00 (2006.01) Inhaling devices

A61M 15/08 (2006.01) Inhaling devices - Inhaling devices inserted into the nose

A61M 16/00 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration

A61M 37/00 (2006.01) Other apparatus for introducing media into the body

A62B 7/00 (2006.01) Respirators

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110441 Priority application(s): WO2005/110441

17 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244079-The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant

2005244072-Antibodies